We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
- Authors
Serruys, P W; Foley, D P; Jackson, G; Bonnier, H; Macaya, C; Vrolix, M; Branzi, A; Shepherd, J; Suryapranata, H; de Feyter, P J; Melkert, R; van Es, G A; Pfister, P J
- Abstract
The 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors competitively inhibit biosynthesis of mevalonate, a precursor of non-sterol compounds involved in cell proliferation. Experimental evidence suggests that fluvastatin may, independent of any lipid lowering action, exert a greater direct inhibitory effect on proliferating vascular myocytes than other statins. The FLARE (Fluvastatin Angioplasty Restenosis) Trial was conceived to evaluate the ability of fluvastatin 40 mg twice daily to reduce restenosis after successful coronary balloon angioplasty (PTCA).
- Publication
European heart journal, 1999, Vol 20, Issue 1, p58
- ISSN
0195-668X
- Publication type
Journal Article
- DOI
10.1053/euhj.1998.1150